<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
68225-124-00
</NDCCode>
<PackageDescription>
147 VIAL, SINGLE-USE in 1 BOX (68225-124-00) / 10 mL in 1 VIAL, SINGLE-USE
</PackageDescription>
<NDC11Code>
68225-0124-00
</NDC11Code>
<ProductNDC>
68225-124
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Reteplase
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
19961030
</StartMarketingDate>
<EndMarketingDate>
20241231
</EndMarketingDate>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Patheon Italia S.p.A.
</LabelerName>
<SubstanceName>
RETEPLASE
</SubstanceName>
<StrengthNumber>
1.81
</StrengthNumber>
<StrengthUnit>
mg/mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
30-OCT-96
</StartMarketingDatePackage>
<EndMarketingDatePackage>
31-DEC-24
</EndMarketingDatePackage>
<SamplePackage/>
</NDC>